Mikrobiomik

Mikrobiomik

Private
DerioHealthcare & Life Scienceshttps://mikrobiomik.net/

Last Round

Crowdfunding

Sep 30, 2025

Est. Valuation

$16.68M

Total Funding Raised

$1.89M

Momentum Score

25 /100

Company Overview

Mikrobiomik is a biotechnology company that researches, develops, and produces biological medicines based on the intestinal microbiota.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Pharma Supply Chain

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

microbiome therapyhuman microbiomeoral microbiota therapyCDI treatmentgut microbiomefecal microbiota transplantpoop pilllive biotherapeutic productClostridioides difficile infectionbiological medicinesdrug developmentGMP manufacturingSoHO Regulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mikrobiomik Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Mikrobiomik Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingSep 30, 2025
VC RoundMar 1, 2025
Series AApr 29, 2024
VC RoundMar 1, 2024
VC RoundSep 25, 2023
VC Round
Mar 11, 2022

Mikrobiomik Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    Monthly visitors increased 36% MoM, reaching 5.3K.

  • Sep 30, 2025

    $706K raised in a crowdfunding round.

Mikrobiomik Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Mikrobiomik Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Mikrobiomik's valuation, stock price, and market status.

Firmographic Details

HeadquartersDerio
Employee Range21
Year Founded2018
Last FundingSep 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.